AB Cernelle
Ken Tinebo is a dynamic and experienced professional with a background in business administration and naval medicine. Their career spans across various leadership roles in reputable companies such as AB Cernelle, KAT Consulting, Nutricia Medical Nutrition, Orion Pharma Ltd, AstraZeneca, and Pharmacia Corporation. With a focus on vision, team alignment, and execution excellence, their expertise in the extraction and processing of pollen for medical treatment has positioned him as a global leader in the industry. Through their education at institutions such as INSEAD, Lund University, Stockholm School of Economics, and Jönköping University, Ken Tinebo has honed their skills in change management and strategic leadership.
This person is not in any teams
This person is not in any offices
AB Cernelle
Cernelle is a pharmaceutical company with research, development, manufacture and distribution of medicine in urology; chronic prostatitis/pelvic pain syndrome (CP/CPPS) and benign prostate enlargement (BPH). Founded 1953 in Sweden, Cernelle was first to extract, process and purify pollen grains for medical use. The extracting methods were further developed to extract pollen in large scales and to produce, the today worldwide established, Cernitin™ pollen extracts. With endless curiosity and strong determination, we have set out to accelerate our leadership in extracting and purifying pollen grains in products for medical use. Cernelle is located in the rural area Vegeholm in southern Sweden, where fields and pastures create a patchwork rich in colours and scents. This is where it all began, and this is where we will continue to evolve and build a prosperous future.” In order to manage the ongoing expansion and growth , Cernelle expects to recruit 25-30 talented and skilled people the upcoming years.